Skip to content

Neuromodulation With Transcranial Direct Current Stimulation (tDCS) to Control Excess Weight

Neuromodulation With Transcranial Direct Current Stimulation (tDCS) to Control Excess Weight

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03351426
Enrollment
40
Registered
2017-11-22
Start date
2016-09-01
Completion date
2018-05-31
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

obesity, overweight, neuromodulation, transcranial direct current stimulation (tDCS)

Brief summary

The purpose of this study is to examine the effects of noninvasive neuromodulation with transcranial direct current stimulation (tDCS) aimed at enhancing the excitability of the left prefrontal cortex in middle-aged women with excess body weight. This is a randomized, parallel, double-blind study with a duration of 4 weeks. Outcome measures will include changes in performance in a computerized task assessing executive functions, subjective measures of food craving and appetite and changes in body weight.

Detailed description

A total of 40 subjects with overweight or class I obesity will be enrolled and randomized into either Group 1) Active tDCS or Group 2) Sham (control) tDCS. The duration of the study will be 4 weeks. During the first two weeks participants will receive eight sessions of tDCS. At week 2 they will also start a hypocaloric diet. The stimulation sessions (duration: 20 minutes, intensity: 2 mA) will be applied once daily (5 days in a row) during the first week and 3 alternate days (Monday, Wednesday and Friday) during the second week. At week 2 and until the end of the study subjects will also start a hypocaloric diet. The study aims are: 1. To examine whether anodal tDCS applied over the left prefrontal cortex can improve executive functions/inhibitory control and reduce subjective ratings of food craving and appetite. 2. To study whether anodal tDCS applied over the left prefrontal cortex, in combination with a hypocaloric diet, can facilitate weight reduction and maintenance over time.

Interventions

DEVICETranscranial Direct Current Stimulation (tDCS)

Transcranial Direct Current Stimulation (tDCS) is a noninvasive form of neuromodulation that uses constant, low-intensity direct current delivered via electrodes that are placed on the head.

Sponsors

University of Alcala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The study is double blind. Neither the participants or the investigator delivering the intervention and collecting the outcomes will be aware of the group allocation. This is achieved via sham tDCS procedure and blinding of tDCS parameters with code system.

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index (BMI) between 25 and 35 kg/m2

Exclusion criteria

* Endocrinology disorder, such as diabetes mellitus or thyroid disease * Addiction * Neurological, psychiatric or any other major medical condition * Hormonal therapy * Contraindications to receive tDCS (past history of seizures or epilepsy, metallic implants on the head, skin disease or lesions in the area to be stimulated).

Design outcomes

Primary

MeasureTime frameDescription
Body weightBaseline, 4 weeks (end of the study)Change

Secondary

MeasureTime frameDescription
Appetite (hunger)Baseline, 4 weeks (end of the study)Change, evaluated via visual analogue scale (VAS). Self-reported scores to the question How hungry are you? representing the current state of the participant will be assessed with a horizontal line, 100 mm in length, anchored by the word descriptors Not at all and Extremely, following standard methods, based on Blundell et al 2009.
Food cravingBaseline, 4 weeks (end of the study)Change, evaluated via scores in the State Food Craving Questionnaire developed by Cepeda-Benito (Moreno et al 2008).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026